Q2 2025 Healthcare Global Enterprises Ltd Earnings Call Transcript
Key Points
- HealthCare Global Enterprises Ltd (NSE:HCG) reported a robust 14% year-on-year revenue growth for Q2 FY25, reaching INR553.5 crores.
- The company's adjusted EBITDA crossed INR100 crores for the first time, showing a strong growth of 21% year-on-year.
- HCG's oncology business experienced impressive 20% growth after adjusting for the exited center in MSR, Bangalore.
- The company has successfully operationalized a new state-of-the-art 200-bedded comprehensive cancer care center in Ahmedabad.
- Digital initiatives have significantly boosted patient acquisition, with digital channel revenue rising to 14% of overall revenue in Q2 FY25, up from 4% in Q2 FY23.
- International revenue declined by 17% due to geopolitical challenges in markets like Bangladesh.
- The South Mumbai center faced challenges due to a decline in international business, impacting overall performance.
- The company incurred a loss of INR3.8 crores to INR4 crores in the South Bombay hospital for the first half of FY25.
- There was a one-time other income of INR5 crores, which will not continue in future quarters.
- The company is facing challenges in achieving double-digit ROCE in emerging centers, particularly in South Mumbai.
Ladies and gentlemen, welcome to the Q2 and H1 FY25 earnings conference call of Healthcare Global Enterprises Limited.
This conference call may contain forward-looking statements about the company, which are based on beliefs, opinions and expectations of the company as on the date of this call. These statements do not guarantee the future performance of the company, and it can involve risks and uncertainties that are difficult to predict. (Operator Instructions) Please note that this conference call is being recorded.
Now I hand over the conference to Dr. B. S. Ajaikumar, Executive Chairman of Healthcare Global Enterprises Limited. Thank you, and over to you, sir.
In the Q2 earnings conference call for HealthCare Global Enterprise Limited, today, I am joined by Mr. Raj Gore, CEO; Ms. Ruby Ritolia, CFO; and senior management team, along with SGA, our Investor Relations adviser.
I am proud to announce a robust financial and operational
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
